Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients

Abstract

The serum FGF19 level has a close relation with endogenous beta cell function among DM subjects, as assessed by the ISSI-2. As ISSI-2 is higher in N-DM group, FGF19 may be a main protector in dysfunction of beta cell.